These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22459665)

  • 21. Assessing the role of basic control measures, antivirals and vaccine in curtailing pandemic influenza: scenarios for the US, UK and the Netherlands.
    Nuño M; Chowell G; Gumel AB
    J R Soc Interface; 2007 Jun; 4(14):505-21. PubMed ID: 17251132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variation in loss of immunity shapes influenza epidemics and the impact of vaccination.
    Woolthuis RG; Wallinga J; van Boven M
    BMC Infect Dis; 2017 Sep; 17(1):632. PubMed ID: 28927373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can antiviral drugs contain pandemic influenza transmission?
    Becker NG; Wang D
    PLoS One; 2011 Mar; 6(3):e17764. PubMed ID: 21464934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Explaining rapid reinfections in multiple-wave influenza outbreaks: Tristan da Cunha 1971 epidemic as a case study.
    Camacho A; Ballesteros S; Graham AL; Carrat F; Ratmann O; Cazelles B
    Proc Biol Sci; 2011 Dec; 278(1725):3635-43. PubMed ID: 21525058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drivers and consequences of influenza antiviral resistant-strain emergence in a capacity-constrained pandemic response.
    Dafilis MP; Moss R; McVernon J; McCaw J
    Epidemics; 2012 Dec; 4(4):219-26. PubMed ID: 23351374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decision making with regard to antiviral intervention during an influenza pandemic.
    Shim E; Chapman GB; Galvani AP
    Med Decis Making; 2010; 30(4):E64-81. PubMed ID: 20634545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strain Interactions as a Mechanism for Dominant Strain Alternation and Incidence Oscillation in Infectious Diseases: Seasonal Influenza as a Case Study.
    Zhang XS
    PLoS One; 2015; 10(11):e0142170. PubMed ID: 26562668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimal control of vaccination dynamics during an influenza epidemic.
    Jaberi-Douraki M; Moghadas SM
    Math Biosci Eng; 2014 Oct; 11(5):1045-63. PubMed ID: 25347806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamics of annual influenza A epidemics with immuno-selection.
    Andreasen V
    J Math Biol; 2003 Jun; 46(6):504-36. PubMed ID: 12783180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of vaccination and population structure on influenza epidemic spread in the presence of two circulating strains.
    Alexander ME; Kobes R
    BMC Public Health; 2011 Feb; 11 Suppl 1(Suppl 1):S8. PubMed ID: 21356137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sensitivity analysis of an individual-based model for simulation of influenza epidemics.
    Nsoesie EO; Beckman RJ; Marathe MV
    PLoS One; 2012; 7(10):e45414. PubMed ID: 23144693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of weekday social contact patterns on the modeling of influenza transmission, and determination of the influenza latent period.
    Towers S; Chowell G
    J Theor Biol; 2012 Nov; 312():87-95. PubMed ID: 22871362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are we prepared for the next influenza pandemic? Lessons from modelling different preparedness policies against four pandemic scenarios.
    Panovska-Griffiths J; Grieco L; van Leeuwen E; Baguelin M; Pebody R; Utley M
    J Theor Biol; 2019 Nov; 481():223-232. PubMed ID: 31059716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Capturing the transmission dynamics of the 2009 Japanese pandemic influenza H1N1 in the presence of heterogeneous immunity.
    Endo A; Ejima K; Nishiura H
    Ann Epidemiol; 2018 May; 28(5):293-300.e1. PubMed ID: 29510905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Likely effectiveness of pharmaceutical and non-pharmaceutical interventions for mitigating influenza virus transmission in Mongolia.
    Bolton KJ; McCaw JM; Moss R; Morris RS; Wang S; Burma A; Darma B; Narangerel D; Nymadawa P; McVernon J
    Bull World Health Organ; 2012 Apr; 90(4):264-71. PubMed ID: 22511822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of changing host immunity on 1918-19 pandemic dynamics.
    Bolton KJ; McCaw JM; McVernon J; Mathews JD
    Epidemics; 2014 Sep; 8():18-27. PubMed ID: 25240900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemic dynamics and antigenic evolution in a single season of influenza A.
    Boni MF; Gog JR; Andreasen V; Feldman MW
    Proc Biol Sci; 2006 Jun; 273(1592):1307-16. PubMed ID: 16777717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of cellular immunity in influenza H1N1 population dynamics.
    Duvvuri VR; Heffernan JM; Moghadas SM; Duvvuri B; Guo H; Fisman DN; Wu J; Wu GE
    BMC Infect Dis; 2012 Nov; 12():329. PubMed ID: 23192104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incorporating demographic stochasticity into multi-strain epidemic models: application to influenza A.
    Minayev P; Ferguson N
    J R Soc Interface; 2009 Nov; 6(40):989-96. PubMed ID: 19158010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.